News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Oncovita Receives U.S. FDA Orphan Drug Designation for MVdeltaC in Treating Pleural Mesothelioma
Thursday, June 05, 2025Oncovita a biotechnology company focused on virusbased immunotherapies has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its lead candidate MVdeltaC
Cadonilimab Approved in China for First-Line Treatment of Cervical Cancer—Third Indication for Akeso’s Bispecific Antibody
Thursday, June 05, 2025Akeso Inc has received approval from Chinas National Medical Products Administration NMPA for the use of its PDCTLA bispecific antibody cadonilimab as a firstline treatment for patients with persistent recurrent or metastatic cervical cancer The ther...
Camurus and Lilly Sign Agreement for Global Development of Long-Acting FluidCrystal® Incretins
Wednesday, June 04, 2025Camurus and Eli Lilly and Company have entered into a collaboration and licence agreement that gives Lilly exclusive global rights to develop produce and market longacting incretinbased treatments
Transpire Bio Signs Exclusive Licensing Deal with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
Wednesday, June 04, 2025Transpire Bio Inc a clinicalstage biopharmaceutical company based in the United States and specialising in inhaled treatments for lung and systemic diseases has entered into an exclusive licensing agreement with Suzhou Intragrand Pharma Co
BioNTech and Bristol Myers Squibb Form Global Partnership to Develop and Market Bispecific Antibody BNT327 for Solid Tumours
Tuesday, June 03, 2025BioNTech SE and Bristol Myers Squibb BMS have entered into a global strategic partnership to codevelop and cocommercialise BNT an experimental bispecific antibody being developed for the treatment of various solid tumours
ASP Isotopes and Isotopia Sign Agreement to Supply Gadolinium-160 for Terbium-161 Production in Cancer Treatment
Tuesday, June 03, 2025ASP Isotopes Inc and Isotopia Molecular Imaging Ltd have entered into a supply agreement focused on Gadolinium Gd a vital stable isotope used in the production of Terbium Tb
Nxera Pharma Reaches Key Development Milestone in Partnership with Eli Lilly for Metabolic Disease Treatments
Monday, June 02, 2025Nxera Pharma Co Ltdhas reached a significant development milestone as part of its ongoing multitarget collaboration and licence agreement with Eli Lilly and Company This achievement relates to research efforts
Mabwell Gains NMPA Approval for Albipagrastim Alfa for Injection (MAILISHENG)
Saturday, May 31, 2025Mabwell SH an innovationfocused biopharmaceutical company has received marketing approval from the National Medical Products Administration NMPA in China for Albipagrastim alfa for Injection marketed under the trade name MAILISHENG The drug developed...
Beam Therapeutics Receives U.S. FDA Orphan Drug Designation for BEAM-302 to Treat Alpha-1 Antitrypsin Deficiency
Friday, May 30, 2025Beam Therapeutics Inc a biotechnology firm focused on precision genetic medicines through base editing has received orphan drug designation from the US Food and Drug Administration FDA for its investigational therapy
Sevabertinib (BAY 2927088) Receives FDA Priority Review for HER2-Mutant Non-Small Cell Lung Cancer
Thursday, May 29, 2025Bayers investigational therapy sevabertinib BAY has been granted Priority Review by the US Food and Drug Administration FDA for the treatment of adults with advanced nonsmall cell lung cancer
